drugset / Trial / NCT05981963
A Study to Evaluate the Drug Levels, Physical and Chemical Changes, and Removal of BMS-986196 in Healthy Male Participants
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the excretion pathway of orally administered \[14C\]-BMS-986196 and to assess the safety and tolerability of orally administered BMS-986196.
Timeline
- Start
- 2023-08-17
- Primary completion
- 2023-10-22
- Completion
- 2023-10-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-986196 | Unknown | 60 mg | Oral |
Indications
No indication recorded.